Inspire Corporate Bond ETF Announces Dividend of $0.07 (NYSEARCA:IBD)

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Based on an average trading volume of 514,400 shares, the […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Robert Negrin ,Davidt Scadden ,Derrickj Rossi ,Johnf Dipersio ,Luigi Naldini ,Alan Tyndall ,Magenta Therapeutics Company Profile ,Acadian Asset Management ,Magenta Therapeutics Inc ,Nasdaq ,Walleye Capital ,Jpmorgan Chase Co ,Magenta Therapeutics ,Get Rating ,Street Corp ,Asset Management ,Jason Gardner ,Magenta Therapeutics Daily ,